Hyro Secures Series B Extension to Advance AI-Powered Healthcare Communications
Hyro enables healthcare providers to automate patient interactions while maintaining compliance with industry standards.
Company Name: Hyro
Location: New York City, NY
Industry: Healthcare AI and Conversational Technology
Funding Details:
- Amount: Undisclosed (Series B extension)
- Investors: Healthier Capital, Macquarie Capital, Liberty Mutual, Twilio Inc., Black Opal Ventures
- Total Funding to Date: $50M
Purpose of Investment:
The funds will support the expansion of Hyro’s AI-powered healthcare communications platform, enhancing its automation capabilities and broadening its reach across healthcare systems.
Leadership:
- CEO: Israel Krush
- CIO: Rom Cohen
Product:
Hyro offers a responsible AI-powered communications platform designed for the healthcare sector. Its platform automates workflows and conversations securely across various platforms, including call centers, websites, SMS, and mobile apps.
About the Company:
Hyro enables healthcare providers to automate patient interactions while maintaining compliance with industry standards. By streamlining communication channels, the platform enhances operational efficiency and patient engagement.
Notable Clients:
Intermountain Health, Baptist Health, Hackensack Meridian Health.
